The Anti-Stretch Marks Agents Market is projected to grow from USD 1,402.1 million in 2025 to USD 3,102.3 million by 2035, at a CAGR of 8.3%. Peptide-based ingredients will dominate with a 61.0% share, while encapsulated delivery systems will lead with a 65.0% share in 2025.